Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)

  • Technology appraisal guidance
  • TA23
  • Published: 
  • Last updated: 
Download guidance (PDF)

8 Review of Guidance

8.1 Information on the review of the guidance on this technology is available on the NICE website.

Andrew Dillon
Chief Executive
April 2001